Get started
CV Sciences, Inc.CV Sciences, Inc.CV Sciences, Inc.

CV Sciences, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

CVSI trade ideas

$CVSI CV Sciences, Inc. 30% Upside CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA.
OTC:CVSILong
by OTCMarketsExpert
$CVSI Flashing Signs of Potential Bottom?CVSI had a brutal last year, but is fighting for fresh support and just broke the longstanding bear trendline suggesting that a turnaround could be in the cards. ----------------------------- CV Sciences Inc (OTCMKTS:CVSI) CV Sciences bills itself as a company that operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The stock was the singular breakout market leader in the CBD space in 2018 until it got chopped down, first by Citron’s Andrew Left in a series of bearish tweets, and second by the cannabis and CBD bear market that dominated 2019. Now, with a fresh hold of the dollar level, the possibility of a recovery year beckons in 2020.
OTC:CVSI
by GregFolin
CV Sciences, Inc On watchlist for reversal opportunity CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, California.
OTC:CVSI
by OTCMarketsExpert
1
CV Science a good risk reward tradeEntry level $2.50 with stop loss $2.15 = Profit target $4.00 Average Analysts recommendation = buy with a $6.33 price target. CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, California.
OTC:CVSILong
by OTCMarketsExpert
$CVSI Forming A V Bottom$CVSI has been beaten up along with the rest of the cannabis sector. Recent price action indicates that the low might be in as the critical $1.55 support level held. Next major resistance level is $3. Those that want to go Long can buy with a stop below $1.55 and add to the position on a break above $3. $CVSI is well-known because of its top-selling PlusCBD oil. For those that want more info, we've included a link to our recent article, which has more info on $CVSI. As always, trade with caution and use protective stops. Good luck to all!
OTC:CVSILong
by InsiderFinancial
2
$CVSI CV SCIENCE JUMPS ON CONTRACT WINCV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, California. CORPORATE NEWS RELEASE (GLOBE NEWSWIRE) -- CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to announce further expansion of its industry-dominating PlusCBD™ Oil brand into the specialty retail channel with The Vitamin Shoppe, Inc. (VSI). CV Sciences’ expansion broadens distribution and availability of a broad assortment of the Company’s best-selling PlusCBD™ Oil products. Distribution across The Vitamin Shoppe’s national footprint includes both topical products, such as PlusCBD™ Oil Extra Strength Balm and recently launched PlusCBD™ Oil Roll-On, as well as PlusCBD™ Oil full spectrum hemp extracts including Gold Formula Softgels, Gold Formula Drops, and Total Plant Complex Sprays and Capsules. PlusCBD™ Oil products will be available beginning on September 22, 2019 at 383 Vitamin Shoppe stores in 30 U.S. states and Puerto Rico. This expansion brings CV Sciences’ PlusCBD™ Oil distribution to more than 5,300 retail locations throughout the U.S. “The Vitamin Shoppe is an ideal retail partner for CV Sciences as we continue our rapid expansion into national retailers,” said Joseph Dowling, Chief Executive Officer of CV Sciences. “Their customers are savvy shoppers focused on health and wellness with a keen eye for high quality, efficacious products that promote a healthy lifestyle. We are very pleased to kick off our partnership with The Vitamin Shoppe and bring PlusCBD™ Oil products to their discerning shoppers.” “The Vitamin Shoppe is excited to introduce PlusCBD™ to our assortment of trusted CBD hemp extract products,” said Sharon Leite, Chief Executive Officer of The Vitamin Shoppe. “This category has generated immense interest from wellness consumers as they seek out the innovative benefits of CBD hemp extract. At The Vitamin Shoppe, our customers can shop these products with the confidence of knowing we offer industry-leading quality, service and guidance with all of our products and each of our partner brands.” PlusCBD™ Oil has the top-selling CBD supplement in the Total U.S. Natural Channel and its Extra Strength Balm ranks #1 in sales in both the Total U.S. Natural Channel and Total U.S. MULO (Multi Outlet) over the last 52 weeks* among CBD products within Topical Analgesics , according to SPINS and IRI data, respectively. Brightfield Group, a leading predictive analytics and market research firm for the CBD market, expects $1.3 billion in sales of hemp CBD topicals in 2019, with a compound annual growth rate of 169% from 2018 – 2022.
OTC:CVSILong
by OTCMarketsExpert